Log in

NYSE:HUMHumana Stock Price, Forecast & News

$381.58
-1.17 (-0.31 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$377.20
Now: $381.58
$385.02
50-Day Range
$373.54
MA: $388.97
$410.65
52-Week Range
$208.25
Now: $381.58
$412.70
Volume464,869 shs
Average Volume1.29 million shs
Market Capitalization$50.45 billion
P/E Ratio19.59
Dividend Yield0.65%
Beta0.87
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE South Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2018, the company had approximately 17 million members in medical benefit plans, as well as approximately 6 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Read More
Humana logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.92 out of 5 stars


Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.89 billion
Cash Flow$22.26 per share
Book Value$90.90 per share

Profitability

Net Income$2.71 billion

Miscellaneous

Employees46,000
Market Cap$50.45 billion
Next Earnings Date8/5/2020 (Confirmed)
OptionableOptionable

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Humana (NYSE:HUM) Frequently Asked Questions

How has Humana's stock been impacted by COVID-19 (Coronavirus)?

Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, HUM shares have increased by 16.3% and is now trading at $381.58. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Humana?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Humana.

When is Humana's next earnings date?

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Humana.

How can I listen to Humana's earnings call?

Humana will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) issued its quarterly earnings data on Wednesday, April, 29th. The insurance provider reported $5.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $4.84 by $0.56. The insurance provider earned $18.94 billion during the quarter, compared to the consensus estimate of $18.49 billion. Humana had a return on equity of 21.02% and a net margin of 3.86%. The firm's revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.48 EPS. View Humana's earnings history.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 23rd. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.625 per share on Friday, July 31st. This represents a $2.50 annualized dividend and a dividend yield of 0.66%. The ex-dividend date is Monday, June 29th. View Humana's dividend history.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2020 Pre-Market earnings guidance on Friday, May, 29th. The company provided earnings per share guidance of 18.25-18.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $18.54.

What price target have analysts set for HUM?

20 analysts have issued 12 month target prices for Humana's shares. Their forecasts range from $290.00 to $510.00. On average, they expect Humana's stock price to reach $412.05 in the next twelve months. This suggests a possible upside of 8.0% from the stock's current price. View analysts' price targets for Humana.

Has Humana been receiving favorable news coverage?

Media coverage about HUM stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Humana earned a news impact score of -1.8 on InfoTrie's scale. They also assigned news coverage about the insurance provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Humana.

Are investors shorting Humana?

Humana saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 1,400,000 shares, a decline of 33.3% from the June 15th total of 2,100,000 shares. Based on an average daily trading volume, of 1,210,000 shares, the short-interest ratio is presently 1.2 days. Currently, 1.1% of the company's stock are sold short. View Humana's Current Options Chain.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Visa (V), Walt Disney (DIS), Alibaba Group (BABA), Mastercard (MA), Boeing (BA), salesforce.com (CRM), JPMorgan Chase & Co. (JPM) and CVS Health (CVS).

Who are Humana's key executives?

Humana's management team includes the following people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)
  • Mr. Brian Andrew Kane, Chief Financial Officer (Age 46)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 53)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Healthcare Services (Age 51)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Who are Humana's major shareholders?

Humana's stock is owned by many different institutional and retail investors. Top institutional investors include Wedge Capital Management L L P NC (0.06%), Hexavest Inc. (0.04%), State of Alaska Department of Revenue (0.02%), Envestnet Asset Management Inc. (0.02%), DNB Asset Management AS (0.02%) and Manning & Napier Group LLC (0.01%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval. View institutional ownership trends for Humana.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Hexavest Inc., Envestnet Asset Management Inc., Municipal Employees Retirement System of Michigan, DNB Asset Management AS, Diversified Trust Co, TrimTabs Asset Management LLC, and Ellevest Inc.. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Timothy Alan Wheatley, and Timothy S Huval. View insider buying and selling activity for Humana.

Which institutional investors are buying Humana stock?

HUM stock was acquired by a variety of institutional investors in the last quarter, including Silverleafe Capital Partners LLC, State of Alaska Department of Revenue, Manning & Napier Group LLC, Cypress Capital Group, Fulton Breakefield Broenniman LLC, Private Trust Co. NA, Clarius Group LLC, and Carroll Financial Associates Inc.. View insider buying and selling activity for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $381.58.

How big of a company is Humana?

Humana has a market capitalization of $50.45 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe.

What is Humana's official website?

The official website for Humana is www.humana.com.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]

This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.